Steba Biotech, a privately owned company, has, in collaboration with scientists at the Weizmann Institute of Science, conducted extensive research and development on the prostate cancer treatment TOOKAD® – and now has received marketing authorization to make it available in 31 European countries. Following this regulatory approval, the first patients are currently being treated in top Israeli, German, English, and Italian medical centers.
April 29, 2019
Parkinson’s News Today discusses the research of Prof. Tamar Flash, who uses artificial intelligence – and takes inspiration from the octopus – to find ways to aid people with the disease.
April 23, 2019
There is a reason that a puzzle piece is the symbol of autism spectrum disorder (ASD). Despite all the research, despite the advances, ASD continues to be an enigma. What causes it? Can it be diagnosed earlier? What are the differences between an autistic and a neurotypical brain?
One field of research – the role of the sense of smell – is producing surprising results that could lead to means of early diagnosis and intervention, as well as shed light on the misreading of social cues that is so common in autism.
As The Daily Mail reports, Dr. Gad Asher and colleagues in California have found that exercising at the end of the day can provide up to 50% better performance.
April 18, 2019
Issue 52 of Weizmann Views presents the research of Prof. Michal Schwartz, who pioneered the field of neuroimmunity. She is working on methods for treating Alzheimer’s and other age-related diseases.
The Weizmann Institute brings together scientists from a variety of disciplines to tackle cancer head-on. In the fourth episode of Weizmann in Focus, CEO Dave Doneson highlights a recent headline-making breakthrough from the labs of Profs. Ido Amit and Amos Tanay. Working with hospitals across Israel, the scientists identified a very small number of malignant cells in what is considered a pre-malignant stage of multiple myeloma—the second-most common type of blood cancer. Their discovery holds the promise of earlier, more precise treatment.
On April 2, Patricia Gruber presented the 13th annual Gruber Award for Scientific Excellence to the Weizmann Institute’s Dr. Sivan Refaely-Abramson. Established by Patricia and her late husband, Peter, through their Gruber Foundation, the three-year award recognizes brilliant early-career Weizmann scientists.
April 12, 2019
The project, led by Prof. Eran Segal and his team in the Department of Computer Science and Applied Mathematics and Department of Molecular Cell Biology, aims to use state-of-the-art artificial intelligence technologies to generate personalized predictions for disease risk factors. The 10K project is a longitudinal study designed to collect lifestyle and clinical data from 10,000 individuals who will be recruited from the Israeli population, and is suitable for Hebrew speakers only.
April 08, 2019
The Weizmann Institute’s Prof. Dan Yakir has won this year’s Israel Prize for Research in Geology, Earth Sciences and Atmospheric Sciences, for his groundbreaking insights into the impact of semi-arid forests on the global climate. “At the station he founded in the Yatir Forest, Prof. Yakir explores the interactions between the biosphere and the atmosphere, especially the ways in which vegetation influences the environment and the climate,” Education Minister Naftali Bennett tweeted.
April 02, 2019
©2019 American Committee for the Weizmann Institute of Science
